Share

November 26, 2013; 81 (22) Article

Epilepsy after TIA or stroke in young patients impairs long-term functional outcome

The FUTURE Study

Renate M. Arntz, Noortje A.M. Maaijwee, Loes C.A. Rutten-Jacobs, Hennie C. Schoonderwaldt, Lucille D. Dorresteijn, Ewoud J. van Dijk, Frank-Erik de Leeuw
First published October 30, 2013, DOI: https://doi.org/10.1212/01.wnl.0000436619.25532.f3
Full PDF
Citation
Permissions

Make Comment

See Comments

Downloads
341

Share

Article Information

vol. 81 no. 22 1907-1913
DOI: 
https://doi.org/10.1212/01.wnl.0000436619.25532.f3
PubMed: 
24174587
Published By: 
Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology
Print ISSN: 
0028-3878
Online ISSN: 
1526-632X
History: 
  • Received May 24, 2013
  • Accepted in final form August 26, 2013
  • First Published October 30, 2013.

Article Versions

Copyright & Usage: 
© 2013 American Academy of Neurology

Author Disclosures

    1. Renate M. Arntz, MD,
    2. Noortje A.M. Maaijwee, MD,
    3. Loes C.A. Rutten-Jacobs, MSc,
    4. Hennie C. Schoonderwaldt, MD, PhD,
    5. Lucille D. Dorresteijn, MD, PhD,
    6. Ewoud J. van Dijk, MD, PhD and
    7. Frank-Erik de Leeuw, MD, PhD
  1. Renate M. Arntz, MD,
    2. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  2. Noortje A.M. Maaijwee, MD,
    3. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  3. Loes C.A. Rutten-Jacobs, MSc,
    4. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  4. Hennie C. Schoonderwaldt, MD, PhD,
    5. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  5. Lucille D. Dorresteijn, MD, PhD,
    6. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  6. Ewoud J. van Dijk, MD, PhD and
    7. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  7. Frank-Erik de Leeuw, MD, PhD
    8. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. Editorial Board Aging Health; 2005-2012No financial compensation

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  1. From the Department of Neurology, Radboud University Nijmegen Medical Centre, Donders Institute for Brain, Cognition and Behaviour, Nijmegen, the Netherlands.
  1. Correspondence to Dr. de Leeuw: FrankErik.deLeeuw{at}radboudumc.nl

Article usage

Article usage: October 2013 to November 2023

AbstractFullPdfSource
Oct 20138702Highwire
Nov 201314531765Highwire
Dec 20139361241Highwire
Jan 20143631628Highwire
Feb 201420697Highwire
Mar 201410514Highwire
Apr 201410268Highwire
May 20149487Highwire
Jun 20144434Highwire
Jul 20147648Highwire
Aug 20145927Highwire
Sep 20147767Highwire
Oct 20146376Highwire
Nov 20145731Highwire
Dec 20144010Highwire
Jan 20153343Highwire
Feb 20152801Highwire
Mar 20154236Highwire
Apr 20152431Highwire
May 20152121Highwire
Jun 20151144Highwire
Jul 20152111Highwire
Aug 20151701Highwire
Sep 20154833Highwire
Oct 20152231Highwire
Nov 20152201Highwire
Dec 20153004Highwire
Jan 20162811Highwire
Feb 20162212Highwire
Mar 20162211Highwire
Apr 20161622Highwire
May 20162311Highwire
Jun 20162311Highwire
Jul 20162311Highwire
Aug 20162801Highwire
Sep 20161112Highwire
Oct 20163700Highwire
Nov 20161263Highwire
Dec 20161611Highwire
Jan 20173721Highwire
Feb 20171901Highwire
Mar 20171922Highwire
Apr 2017900Highwire
May 20171500Highwire
Jun 20171500Highwire
Jul 20171811Highwire
Aug 20171562Highwire
Sep 20171611Highwire
Oct 20172001Highwire
Nov 20172121Highwire
Dec 20171500Highwire
Jan 20181200Highwire
Feb 20184021Highwire
Mar 20182510Highwire
Apr 20182131Highwire
May 20181911Highwire
Jun 20181922Highwire
Jul 2018812Highwire
Aug 20181800Highwire
Sep 20182253Highwire
Oct 2018500Highwire
Nov 20182200Highwire
Dec 20181900Highwire
Jan 20191510Highwire
Feb 20191432Highwire
Mar 20193243Highwire
Apr 20192722Highwire
May 20191101Highwire
Jun 20191111Highwire
Jul 20192021Highwire
Aug 2019933Highwire
Sep 20191142Highwire
Oct 20191622Highwire
Nov 20192311Highwire
Dec 20192312Highwire
Jan 20202210Highwire
Feb 20201500Highwire
Mar 20202110Highwire
Apr 20201933Highwire
May 20202711Highwire
Jun 20202313Highwire
Jul 20201100Highwire
Aug 20202533Highwire
Sep 20201410Highwire
Oct 202046231Highwire
Nov 20202821Highwire
Dec 2020800Highwire
Jan 20211200Highwire
Feb 20214322Highwire
Mar 20212631Highwire
Apr 20213821Highwire
May 20214721Highwire
Jun 20212442Highwire
Jul 20213211Highwire
Aug 20212510Highwire
Sep 20211921Highwire
Oct 20212411Highwire
Nov 20214130Highwire
Dec 20211900Highwire
Jan 20225320Highwire
Feb 20223221Highwire
Mar 20222610Highwire
Apr 20222021Highwire
May 20223611Highwire
Jun 20222822Highwire
Jul 20223348Highwire
Aug 20223610Highwire
Sep 20222411Highwire
Oct 20226379Highwire
Nov 20223611Highwire
Dec 20222923Highwire
Jan 20233024Highwire
Feb 20232311Highwire
Mar 20234766Highwire
Apr 20232111Highwire
May 20232910Highwire
Jun 20233400Highwire
Jul 20233100Highwire
Aug 20232400Highwire
Sep 20232311Highwire
Oct 20232800Highwire
Nov 20231411Highwire

Letters: Rapid online correspondence

No comments have been published for this article.
Comment

REQUIREMENTS

You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.

Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.

If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.

Submission specifications:

  • Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
  • Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
  • Submit only on articles published within 6 months of issue date.
  • Do not be redundant. Read any comments already posted on the article prior to submission.
  • Submitted comments are subject to editing and editor review prior to posting.

More guidelines and information on Disputes & Debates

Compose Comment

More information about text formats

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
NOTE: The first author must also be the corresponding author of the comment.
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. [email protected]
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Publishing Agreement
NOTE: All authors, besides the first/corresponding author, must complete a separate Publishing Agreement Form and provide via email to the editorial office before comments can be posted.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Vertical Tabs

You May Also be Interested in

Back to top
Advertisement

Topics Discussed

Alert Me

Recommended articles